FRM
JAZZ icon

Fox Run Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fox Run Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,567
Closed -$287K – 1119
2026
Q1 		$287K Buy
+1,567
New +$274K 0.05% 633
2025
Q4 		– Sell
-10,358
Closed -$1.37M – 1075
2025
Q3 		$1.37M Buy
+10,358
New +$1.24M 0.21% 112
2025
Q2 		– Sell
-10,339
Closed -$1.28M – 1039
2025
Q1 		$1.28M Buy
10,339
+5,918
+134% +$772K 0.2% 125
2024
Q4 		$544K Buy
+4,421
New +$521K 0.1% 410
2024
Q3 		– Sell
-12,766
Closed -$1.36M – 952
2024
Q2 		$1.36M Buy
12,766
+8,393
+192% +$923K 0.26% 92
2024
Q1 		$527K Sell
4,373
-2,068
-32% -$253K 0.11% 355
2023
Q4 		$792K Buy
+6,441
New +$804K 0.2% 152
2023
Q3 		– Sell
-3,953
Closed -$490K – 843
2023
Q2 		$490K Buy
3,953
+471
+14% +$63.4K 0.14% 290
2023
Q1 		$510K Buy
+3,482
New +$515K 0.17% 213
2020
Q1 		– Sell
-1,388
Closed -$207K – 248
2019
Q4 		$207K Buy
+1,388
New +$189K 0.17% 319
2019
Q1 		– Sell
-1,771
Closed -$220K – 578
2018
Q4 		$220K Buy
+1,771
New +$263K 0.12% 376
2018
Q1 		– Sell
-1,874
Closed -$252K – 812
2017
Q4 		$252K Buy
1,874
+74
+4% +$10.3K 0.07% 515
2017
Q3 		$263K Buy
+1,800
New +$272K 0.07% 534

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fox Run Management's JAZZ Position: Q2 2026 in Review

Fox Run Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 1,567 shares — an estimated $287K sold.

Fox Run Management first reported a position in JAZZ in Q3 2017 and held it in 13 quarters. The position peaked at $1.37M in Q3 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Fox Run Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 1,567 Jazz Pharmaceuticals shares in Q2 2026, an estimated $287K.
  • Fox Run Management first reported a position in Jazz Pharmaceuticals in Q3 2017 and held it in 13 quarters.
  • Fox Run Management's Jazz Pharmaceuticals position peaked at $1.37M in Q3 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.